Global Vaccines For Children (VFC) Market Insights and Forecast to 2031

Report ID: 1669356 | Published Date: Jan 2025 | No. of Page: 109 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Vaccines For Children (VFC) Product Introduction
    1.2 Market by Type
        1.2.1 Global Vaccines For Children (VFC) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Recombinant Vaccines
        1.2.3 Viral Vaccines
        1.2.4 Polysaccharide Vaccines
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Vaccines For Children (VFC) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Government Institution
        1.3.3 Private Sector
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Vaccines For Children (VFC) Sales Estimates and Forecasts 2017-2028
    2.2 Global Vaccines For Children (VFC) Revenue Estimates and Forecasts 2017-2028
    2.3 Global Vaccines For Children (VFC) Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Vaccines For Children (VFC) Sales by Region
        2.4.1 Global Vaccines For Children (VFC) Sales by Region (2017-2022)
        2.4.2 Global Sales Vaccines For Children (VFC) by Region (2023-2028)
    2.5 Global Vaccines For Children (VFC) Revenue by Region
        2.5.1 Global Vaccines For Children (VFC) Revenue by Region (2017-2022)
        2.5.2 Global Vaccines For Children (VFC) Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Vaccines For Children (VFC) Sales by Manufacturers
        3.1.1 Global Top Vaccines For Children (VFC) Manufacturers by Sales (2017-2022)
        3.1.2 Global Vaccines For Children (VFC) Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Vaccines For Children (VFC) in 2021
    3.2 Global Vaccines For Children (VFC) Revenue by Manufacturers
        3.2.1 Global Vaccines For Children (VFC) Revenue by Manufacturers (2017-2022)
        3.2.2 Global Vaccines For Children (VFC) Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Vaccines For Children (VFC) Revenue in 2021
    3.3 Global Vaccines For Children (VFC) Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Vaccines For Children (VFC) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Vaccines For Children (VFC) Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Vaccines For Children (VFC) Sales by Type
        4.1.1 Global Vaccines For Children (VFC) Historical Sales by Type (2017-2022)
        4.1.2 Global Vaccines For Children (VFC) Forecasted Sales by Type (2023-2028)
        4.1.3 Global Vaccines For Children (VFC) Sales Market Share by Type (2017-2028)
    4.2 Global Vaccines For Children (VFC) Revenue by Type
        4.2.1 Global Vaccines For Children (VFC) Historical Revenue by Type (2017-2022)
        4.2.2 Global Vaccines For Children (VFC) Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Vaccines For Children (VFC) Revenue Market Share by Type (2017-2028)
    4.3 Global Vaccines For Children (VFC) Price by Type
        4.3.1 Global Vaccines For Children (VFC) Price by Type (2017-2022)
        4.3.2 Global Vaccines For Children (VFC) Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Vaccines For Children (VFC) Sales by Application
        5.1.1 Global Vaccines For Children (VFC) Historical Sales by Application (2017-2022)
        5.1.2 Global Vaccines For Children (VFC) Forecasted Sales by Application (2023-2028)
        5.1.3 Global Vaccines For Children (VFC) Sales Market Share by Application (2017-2028)
    5.2 Global Vaccines For Children (VFC) Revenue by Application
        5.2.1 Global Vaccines For Children (VFC) Historical Revenue by Application (2017-2022)
        5.2.2 Global Vaccines For Children (VFC) Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Vaccines For Children (VFC) Revenue Market Share by Application (2017-2028)
    5.3 Global Vaccines For Children (VFC) Price by Application
        5.3.1 Global Vaccines For Children (VFC) Price by Application (2017-2022)
        5.3.2 Global Vaccines For Children (VFC) Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Vaccines For Children (VFC) Market Size by Type
        6.1.1 North America Vaccines For Children (VFC) Sales by Type (2017-2028)
        6.1.2 North America Vaccines For Children (VFC) Revenue by Type (2017-2028)
    6.2 North America Vaccines For Children (VFC) Market Size by Application
        6.2.1 North America Vaccines For Children (VFC) Sales by Application (2017-2028)
        6.2.2 North America Vaccines For Children (VFC) Revenue by Application (2017-2028)
    6.3 North America Vaccines For Children (VFC) Market Size by Country
        6.3.1 North America Vaccines For Children (VFC) Sales by Country (2017-2028)
        6.3.2 North America Vaccines For Children (VFC) Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Vaccines For Children (VFC) Market Size by Type
        7.1.1 Europe Vaccines For Children (VFC) Sales by Type (2017-2028)
        7.1.2 Europe Vaccines For Children (VFC) Revenue by Type (2017-2028)
    7.2 Europe Vaccines For Children (VFC) Market Size by Application
        7.2.1 Europe Vaccines For Children (VFC) Sales by Application (2017-2028)
        7.2.2 Europe Vaccines For Children (VFC) Revenue by Application (2017-2028)
    7.3 Europe Vaccines For Children (VFC) Market Size by Country
        7.3.1 Europe Vaccines For Children (VFC) Sales by Country (2017-2028)
        7.3.2 Europe Vaccines For Children (VFC) Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Vaccines For Children (VFC) Market Size by Type
        8.1.1 Asia Pacific Vaccines For Children (VFC) Sales by Type (2017-2028)
        8.1.2 Asia Pacific Vaccines For Children (VFC) Revenue by Type (2017-2028)
    8.2 Asia Pacific Vaccines For Children (VFC) Market Size by Application
        8.2.1 Asia Pacific Vaccines For Children (VFC) Sales by Application (2017-2028)
        8.2.2 Asia Pacific Vaccines For Children (VFC) Revenue by Application (2017-2028)
    8.3 Asia Pacific Vaccines For Children (VFC) Market Size by Region
        8.3.1 Asia Pacific Vaccines For Children (VFC) Sales by Region (2017-2028)
        8.3.2 Asia Pacific Vaccines For Children (VFC) Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Vaccines For Children (VFC) Market Size by Type
        9.1.1 Latin America Vaccines For Children (VFC) Sales by Type (2017-2028)
        9.1.2 Latin America Vaccines For Children (VFC) Revenue by Type (2017-2028)
    9.2 Latin America Vaccines For Children (VFC) Market Size by Application
        9.2.1 Latin America Vaccines For Children (VFC) Sales by Application (2017-2028)
        9.2.2 Latin America Vaccines For Children (VFC) Revenue by Application (2017-2028)
    9.3 Latin America Vaccines For Children (VFC) Market Size by Country
        9.3.1 Latin America Vaccines For Children (VFC) Sales by Country (2017-2028)
        9.3.2 Latin America Vaccines For Children (VFC) Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Vaccines For Children (VFC) Market Size by Type
        10.1.1 Middle East and Africa Vaccines For Children (VFC) Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Vaccines For Children (VFC) Revenue by Type (2017-2028)
    10.2 Middle East and Africa Vaccines For Children (VFC) Market Size by Application
        10.2.1 Middle East and Africa Vaccines For Children (VFC) Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Vaccines For Children (VFC) Revenue by Application (2017-2028)
    10.3 Middle East and Africa Vaccines For Children (VFC) Market Size by Country
        10.3.1 Middle East and Africa Vaccines For Children (VFC) Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Vaccines For Children (VFC) Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 GSK
        11.1.1 GSK Corporation Information
        11.1.2 GSK Overview
        11.1.3 GSK Vaccines For Children (VFC) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 GSK Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 GSK Recent Developments
    11.2 Sanofi
        11.2.1 Sanofi Corporation Information
        11.2.2 Sanofi Overview
        11.2.3 Sanofi Vaccines For Children (VFC) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Sanofi Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Sanofi Recent Developments
    11.3 Merck
        11.3.1 Merck Corporation Information
        11.3.2 Merck Overview
        11.3.3 Merck Vaccines For Children (VFC) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Merck Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Merck Recent Developments
    11.4 Pfizer
        11.4.1 Pfizer Corporation Information
        11.4.2 Pfizer Overview
        11.4.3 Pfizer Vaccines For Children (VFC) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Pfizer Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Pfizer Recent Developments
    11.5 Jintan
        11.5.1 Jintan Corporation Information
        11.5.2 Jintan Overview
        11.5.3 Jintan Vaccines For Children (VFC) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Jintan Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Jintan Recent Developments
    11.6 CSL
        11.6.1 CSL Corporation Information
        11.6.2 CSL Overview
        11.6.3 CSL Vaccines For Children (VFC) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 CSL Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 CSL Recent Developments
    11.7 MedImmune LLC
        11.7.1 MedImmune LLC Corporation Information
        11.7.2 MedImmune LLC Overview
        11.7.3 MedImmune LLC Vaccines For Children (VFC) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 MedImmune LLC Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 MedImmune LLC Recent Developments
    11.8 J&J(Crucell)
        11.8.1 J&J(Crucell) Corporation Information
        11.8.2 J&J(Crucell) Overview
        11.8.3 J&J(Crucell) Vaccines For Children (VFC) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 J&J(Crucell) Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 J&J(Crucell) Recent Developments
    11.9 China National Biotec
        11.9.1 China National Biotec Corporation Information
        11.9.2 China National Biotec Overview
        11.9.3 China National Biotec Vaccines For Children (VFC) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 China National Biotec Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 China National Biotec Recent Developments
    11.10 Tiantan
        11.10.1 Tiantan Corporation Information
        11.10.2 Tiantan Overview
        11.10.3 Tiantan Vaccines For Children (VFC) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Tiantan Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Tiantan Recent Developments
    11.11 Hualan
        11.11.1 Hualan Corporation Information
        11.11.2 Hualan Overview
        11.11.3 Hualan Vaccines For Children (VFC) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Hualan Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Hualan Recent Developments
    11.12 Kangtai
        11.12.1 Kangtai Corporation Information
        11.12.2 Kangtai Overview
        11.12.3 Kangtai Vaccines For Children (VFC) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Kangtai Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Kangtai Recent Developments
    11.13 Hissen
        11.13.1 Hissen Corporation Information
        11.13.2 Hissen Overview
        11.13.3 Hissen Vaccines For Children (VFC) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.13.4 Hissen Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 Hissen Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Vaccines For Children (VFC) Industry Chain Analysis
    12.2 Vaccines For Children (VFC) Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Vaccines For Children (VFC) Production Mode & Process
    12.4 Vaccines For Children (VFC) Sales and Marketing
        12.4.1 Vaccines For Children (VFC) Sales Channels
        12.4.2 Vaccines For Children (VFC) Distributors
    12.5 Vaccines For Children (VFC) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Vaccines For Children (VFC) Industry Trends
    13.2 Vaccines For Children (VFC) Market Drivers
    13.3 Vaccines For Children (VFC) Market Challenges
    13.4 Vaccines For Children (VFC) Market Restraints
14 Key Findings in The Global Vaccines For Children (VFC) Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Vaccines For Children (VFC) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Recombinant Vaccines
    Table 3. Major Manufacturers of Viral Vaccines
    Table 4. Major Manufacturers of Polysaccharide Vaccines
    Table 5. Major Manufacturers of Others
    Table 6. Global Vaccines For Children (VFC) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Vaccines For Children (VFC) Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Vaccines For Children (VFC) Sales by Region (2017-2022) & (K Doses)
    Table 9. Global Vaccines For Children (VFC) Sales Market Share by Region (2017-2022)
    Table 10. Global Vaccines For Children (VFC) Sales by Region (2023-2028) & (K Doses)
    Table 11. Global Vaccines For Children (VFC) Sales Market Share by Region (2023-2028)
    Table 12. Global Vaccines For Children (VFC) Revenue by Region (2017-2022) & (US$ Million)
    Table 13. Global Vaccines For Children (VFC) Revenue Market Share by Region (2017-2022)
    Table 14. Global Vaccines For Children (VFC) Revenue by Region (2023-2028) & (US$ Million)
    Table 15. Global Vaccines For Children (VFC) Revenue Market Share by Region (2023-2028)
    Table 16. Global Vaccines For Children (VFC) Sales by Manufacturers (2017-2022) & (K Doses)
    Table 17. Global Vaccines For Children (VFC) Sales Share by Manufacturers (2017-2022)
    Table 18. Global Vaccines For Children (VFC) Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 19. Global Vaccines For Children (VFC) Revenue Share by Manufacturers (2017-2022)
    Table 20. Vaccines For Children (VFC) Price by Manufacturers (2017-2022) &(US$/Dose)
    Table 21. Global Vaccines For Children (VFC) Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Vaccines For Children (VFC) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccines For Children (VFC) as of 2021)
    Table 23. Vaccines For Children (VFC) Manufacturing Base Distribution and Headquarters
    Table 24. Manufacturers Vaccines For Children (VFC) Product Offered
    Table 25. Date of Manufacturers Enter into Vaccines For Children (VFC) Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Vaccines For Children (VFC) Sales by Type (2017-2022) & (K Doses)
    Table 28. Global Vaccines For Children (VFC) Sales by Type (2023-2028) & (K Doses)
    Table 29. Global Vaccines For Children (VFC) Sales Share by Type (2017-2022)
    Table 30. Global Vaccines For Children (VFC) Sales Share by Type (2023-2028)
    Table 31. Global Vaccines For Children (VFC) Revenue by Type (2017-2022) & (US$ Million)
    Table 32. Global Vaccines For Children (VFC) Revenue by Type (2023-2028) & (US$ Million)
    Table 33. Global Vaccines For Children (VFC) Revenue Share by Type (2017-2022)
    Table 34. Global Vaccines For Children (VFC) Revenue Share by Type (2023-2028)
    Table 35. Vaccines For Children (VFC) Price by Type (2017-2022) & (US$/Dose)
    Table 36. Global Vaccines For Children (VFC) Price Forecast by Type (2023-2028) & (US$/Dose)
    Table 37. Global Vaccines For Children (VFC) Sales by Application (2017-2022) & (K Doses)
    Table 38. Global Vaccines For Children (VFC) Sales by Application (2023-2028) & (K Doses)
    Table 39. Global Vaccines For Children (VFC) Sales Share by Application (2017-2022)
    Table 40. Global Vaccines For Children (VFC) Sales Share by Application (2023-2028)
    Table 41. Global Vaccines For Children (VFC) Revenue by Application (2017-2022) & (US$ Million)
    Table 42. Global Vaccines For Children (VFC) Revenue by Application (2023-2028) & (US$ Million)
    Table 43. Global Vaccines For Children (VFC) Revenue Share by Application (2017-2022)
    Table 44. Global Vaccines For Children (VFC) Revenue Share by Application (2023-2028)
    Table 45. Vaccines For Children (VFC) Price by Application (2017-2022) & (US$/Dose)
    Table 46. Global Vaccines For Children (VFC) Price Forecast by Application (2023-2028) & (US$/Dose)
    Table 47. North America Vaccines For Children (VFC) Sales by Type (2017-2022) & (K Doses)
    Table 48. North America Vaccines For Children (VFC) Sales by Type (2023-2028) & (K Doses)
    Table 49. North America Vaccines For Children (VFC) Revenue by Type (2017-2022) & (US$ Million)
    Table 50. North America Vaccines For Children (VFC) Revenue by Type (2023-2028) & (US$ Million)
    Table 51. North America Vaccines For Children (VFC) Sales by Application (2017-2022) & (K Doses)
    Table 52. North America Vaccines For Children (VFC) Sales by Application (2023-2028) & (K Doses)
    Table 53. North America Vaccines For Children (VFC) Revenue by Application (2017-2022) & (US$ Million)
    Table 54. North America Vaccines For Children (VFC) Revenue by Application (2023-2028) & (US$ Million)
    Table 55. North America Vaccines For Children (VFC) Sales by Country (2017-2022) & (K Doses)
    Table 56. North America Vaccines For Children (VFC) Sales by Country (2023-2028) & (K Doses)
    Table 57. North America Vaccines For Children (VFC) Revenue by Country (2017-2022) & (US$ Million)
    Table 58. North America Vaccines For Children (VFC) Revenue by Country (2023-2028) & (US$ Million)
    Table 59. Europe Vaccines For Children (VFC) Sales by Type (2017-2022) & (K Doses)
    Table 60. Europe Vaccines For Children (VFC) Sales by Type (2023-2028) & (K Doses)
    Table 61. Europe Vaccines For Children (VFC) Revenue by Type (2017-2022) & (US$ Million)
    Table 62. Europe Vaccines For Children (VFC) Revenue by Type (2023-2028) & (US$ Million)
    Table 63. Europe Vaccines For Children (VFC) Sales by Application (2017-2022) & (K Doses)
    Table 64. Europe Vaccines For Children (VFC) Sales by Application (2023-2028) & (K Doses)
    Table 65. Europe Vaccines For Children (VFC) Revenue by Application (2017-2022) & (US$ Million)
    Table 66. Europe Vaccines For Children (VFC) Revenue by Application (2023-2028) & (US$ Million)
    Table 67. Europe Vaccines For Children (VFC) Sales by Country (2017-2022) & (K Doses)
    Table 68. Europe Vaccines For Children (VFC) Sales by Country (2023-2028) & (K Doses)
    Table 69. Europe Vaccines For Children (VFC) Revenue by Country (2017-2022) & (US$ Million)
    Table 70. Europe Vaccines For Children (VFC) Revenue by Country (2023-2028) & (US$ Million)
    Table 71. Asia Pacific Vaccines For Children (VFC) Sales by Type (2017-2022) & (K Doses)
    Table 72. Asia Pacific Vaccines For Children (VFC) Sales by Type (2023-2028) & (K Doses)
    Table 73. Asia Pacific Vaccines For Children (VFC) Revenue by Type (2017-2022) & (US$ Million)
    Table 74. Asia Pacific Vaccines For Children (VFC) Revenue by Type (2023-2028) & (US$ Million)
    Table 75. Asia Pacific Vaccines For Children (VFC) Sales by Application (2017-2022) & (K Doses)
    Table 76. Asia Pacific Vaccines For Children (VFC) Sales by Application (2023-2028) & (K Doses)
    Table 77. Asia Pacific Vaccines For Children (VFC) Revenue by Application (2017-2022) & (US$ Million)
    Table 78. Asia Pacific Vaccines For Children (VFC) Revenue by Application (2023-2028) & (US$ Million)
    Table 79. Asia Pacific Vaccines For Children (VFC) Sales by Region (2017-2022) & (K Doses)
    Table 80. Asia Pacific Vaccines For Children (VFC) Sales by Region (2023-2028) & (K Doses)
    Table 81. Asia Pacific Vaccines For Children (VFC) Revenue by Region (2017-2022) & (US$ Million)
    Table 82. Asia Pacific Vaccines For Children (VFC) Revenue by Region (2023-2028) & (US$ Million)
    Table 83. Latin America Vaccines For Children (VFC) Sales by Type (2017-2022) & (K Doses)
    Table 84. Latin America Vaccines For Children (VFC) Sales by Type (2023-2028) & (K Doses)
    Table 85. Latin America Vaccines For Children (VFC) Revenue by Type (2017-2022) & (US$ Million)
    Table 86. Latin America Vaccines For Children (VFC) Revenue by Type (2023-2028) & (US$ Million)
    Table 87. Latin America Vaccines For Children (VFC) Sales by Application (2017-2022) & (K Doses)
    Table 88. Latin America Vaccines For Children (VFC) Sales by Application (2023-2028) & (K Doses)
    Table 89. Latin America Vaccines For Children (VFC) Revenue by Application (2017-2022) & (US$ Million)
    Table 90. Latin America Vaccines For Children (VFC) Revenue by Application (2023-2028) & (US$ Million)
    Table 91. Latin America Vaccines For Children (VFC) Sales by Country (2017-2022) & (K Doses)
    Table 92. Latin America Vaccines For Children (VFC) Sales by Country (2023-2028) & (K Doses)
    Table 93. Latin America Vaccines For Children (VFC) Revenue by Country (2017-2022) & (US$ Million)
    Table 94. Latin America Vaccines For Children (VFC) Revenue by Country (2023-2028) & (US$ Million)
    Table 95. Middle East and Africa Vaccines For Children (VFC) Sales by Type (2017-2022) & (K Doses)
    Table 96. Middle East and Africa Vaccines For Children (VFC) Sales by Type (2023-2028) & (K Doses)
    Table 97. Middle East and Africa Vaccines For Children (VFC) Revenue by Type (2017-2022) & (US$ Million)
    Table 98. Middle East and Africa Vaccines For Children (VFC) Revenue by Type (2023-2028) & (US$ Million)
    Table 99. Middle East and Africa Vaccines For Children (VFC) Sales by Application (2017-2022) & (K Doses)
    Table 100. Middle East and Africa Vaccines For Children (VFC) Sales by Application (2023-2028) & (K Doses)
    Table 101. Middle East and Africa Vaccines For Children (VFC) Revenue by Application (2017-2022) & (US$ Million)
    Table 102. Middle East and Africa Vaccines For Children (VFC) Revenue by Application (2023-2028) & (US$ Million)
    Table 103. Middle East and Africa Vaccines For Children (VFC) Sales by Country (2017-2022) & (K Doses)
    Table 104. Middle East and Africa Vaccines For Children (VFC) Sales by Country (2023-2028) & (K Doses)
    Table 105. Middle East and Africa Vaccines For Children (VFC) Revenue by Country (2017-2022) & (US$ Million)
    Table 106. Middle East and Africa Vaccines For Children (VFC) Revenue by Country (2023-2028) & (US$ Million)
    Table 107. GSK Corporation Information
    Table 108. GSK Description and Major Businesses
    Table 109. GSK Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 110. GSK Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. GSK Recent Developments
    Table 112. Sanofi Corporation Information
    Table 113. Sanofi Description and Major Businesses
    Table 114. Sanofi Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 115. Sanofi Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Sanofi Recent Developments
    Table 117. Merck Corporation Information
    Table 118. Merck Description and Major Businesses
    Table 119. Merck Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 120. Merck Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Merck Recent Developments
    Table 122. Pfizer Corporation Information
    Table 123. Pfizer Description and Major Businesses
    Table 124. Pfizer Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 125. Pfizer Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Pfizer Recent Developments
    Table 127. Jintan Corporation Information
    Table 128. Jintan Description and Major Businesses
    Table 129. Jintan Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 130. Jintan Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Jintan Recent Developments
    Table 132. CSL Corporation Information
    Table 133. CSL Description and Major Businesses
    Table 134. CSL Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 135. CSL Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. CSL Recent Developments
    Table 137. MedImmune LLC Corporation Information
    Table 138. MedImmune LLC Description and Major Businesses
    Table 139. MedImmune LLC Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 140. MedImmune LLC Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. MedImmune LLC Recent Developments
    Table 142. J&J(Crucell) Corporation Information
    Table 143. J&J(Crucell) Description and Major Businesses
    Table 144. J&J(Crucell) Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 145. J&J(Crucell) Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. J&J(Crucell) Recent Developments
    Table 147. China National Biotec Corporation Information
    Table 148. China National Biotec Description and Major Businesses
    Table 149. China National Biotec Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 150. China National Biotec Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 151. China National Biotec Recent Developments
    Table 152. Tiantan Corporation Information
    Table 153. Tiantan Description and Major Businesses
    Table 154. Tiantan Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 155. Tiantan Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 156. Tiantan Recent Developments
    Table 157. Hualan Corporation Information
    Table 158. Hualan Description and Major Businesses
    Table 159. Hualan Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 160. Hualan Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 161. Hualan Recent Developments
    Table 162. Kangtai Corporation Information
    Table 163. Kangtai Description and Major Businesses
    Table 164. Kangtai Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 165. Kangtai Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 166. Kangtai Recent Developments
    Table 167. Hissen Corporation Information
    Table 168. Hissen Description and Major Businesses
    Table 169. Hissen Vaccines For Children (VFC) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 170. Hissen Vaccines For Children (VFC) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 171. Hissen Recent Developments
    Table 172. Key Raw Materials Lists
    Table 173. Raw Materials Key Suppliers Lists
    Table 174. Vaccines For Children (VFC) Distributors List
    Table 175. Vaccines For Children (VFC) Customers List
    Table 176. Vaccines For Children (VFC) Market Trends
    Table 177. Vaccines For Children (VFC) Market Drivers
    Table 178. Vaccines For Children (VFC) Market Challenges
    Table 179. Vaccines For Children (VFC) Market Restraints
    Table 180. Research Programs/Design for This Report
    Table 181. Key Data Information from Secondary Sources
    Table 182. Key Data Information from Primary Sources
List of Figures
    Figure 1. Vaccines For Children (VFC) Product Picture
    Figure 3. Global Vaccines For Children (VFC) Market Share by Type in 2021 & 2028
    Figure 3. Recombinant Vaccines Product Picture
    Figure 4. Viral Vaccines Product Picture
    Figure 5. Polysaccharide Vaccines Product Picture
    Figure 6. Others Product Picture
    Figure 7. Global Vaccines For Children (VFC) Market Share by Application in 2021 & 2028
    Figure 8. Government Institution
    Figure 9. Private Sector
    Figure 10. Other
    Figure 11. Vaccines For Children (VFC) Report Years Considered
    Figure 12. Global Vaccines For Children (VFC) Sales 2017-2028 (K Doses)
    Figure 13. Global Vaccines For Children (VFC) Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Vaccines For Children (VFC) Revenue 2017-2028 (US$ Million)
    Figure 15. Global Vaccines For Children (VFC) Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 16. Global Vaccines For Children (VFC) Sales Market Share by Region (2017-2022)
    Figure 17. Global Vaccines For Children (VFC) Sales Market Share by Region (2023-2028)
    Figure 18. North America Vaccines For Children (VFC) Sales YoY (2017-2028) & (K Doses)
    Figure 19. North America Vaccines For Children (VFC) Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Europe Vaccines For Children (VFC) Sales YoY (2017-2028) & (K Doses)
    Figure 21. Europe Vaccines For Children (VFC) Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Asia-Pacific Vaccines For Children (VFC) Sales YoY (2017-2028) & (K Doses)
    Figure 23. Asia-Pacific Vaccines For Children (VFC) Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Latin America Vaccines For Children (VFC) Sales YoY (2017-2028) & (K Doses)
    Figure 25. Latin America Vaccines For Children (VFC) Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Middle East & Africa Vaccines For Children (VFC) Sales YoY (2017-2028) & (K Doses)
    Figure 27. Middle East & Africa Vaccines For Children (VFC) Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. The Vaccines For Children (VFC) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 29. The Top 5 and 10 Largest Manufacturers of Vaccines For Children (VFC) in the World: Market Share by Vaccines For Children (VFC) Revenue in 2021
    Figure 30. Global Vaccines For Children (VFC) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 31. Global Vaccines For Children (VFC) Sales Market Share by Type (2017-2028)
    Figure 32. Global Vaccines For Children (VFC) Revenue Market Share by Type (2017-2028)
    Figure 33. Global Vaccines For Children (VFC) Sales Market Share by Application (2017-2028)
    Figure 34. Global Vaccines For Children (VFC) Revenue Market Share by Application (2017-2028)
    Figure 35. North America Vaccines For Children (VFC) Sales Market Share by Type (2017-2028)
    Figure 36. North America Vaccines For Children (VFC) Revenue Market Share by Type (2017-2028)
    Figure 37. North America Vaccines For Children (VFC) Sales Market Share by Application (2017-2028)
    Figure 38. North America Vaccines For Children (VFC) Revenue Market Share by Application (2017-2028)
    Figure 39. North America Vaccines For Children (VFC) Sales Share by Country (2017-2028)
    Figure 40. North America Vaccines For Children (VFC) Revenue Share by Country (2017-2028)
    Figure 41. U.S. Vaccines For Children (VFC) Revenue (2017-2028) & (US$ Million)
    Figure 42. Canada Vaccines For Children (VFC) Revenue (2017-2028) & (US$ Million)
    Figure 43. Europe Vaccines For Children (VFC) Sales Market Share by Type (2017-2028)
    Figure 44. Europe Vaccines For Children (VFC) Revenue Market Share by Type (2017-2028)
    Figure 45. Europe Vaccines For Children (VFC) Sales Market Share by Application (2017-2028)
    Figure 46. Europe Vaccines For Children (VFC) Revenue Market Share by Application (2017-2028)
    Figure 47. Europe Vaccines For Children (VFC) Sales Share by Country (2017-2028)
    Figure 48. Europe Vaccines For Children (VFC) Revenue Share by Country (2017-2028)
    Figure 49. Germany Vaccines For Children (VFC) Revenue (2017-2028) & (US$ Million)
    Figure 50. France Vaccines For Children (VFC) Revenue (2017-2028) & (US$ Million)
    Figure 51. U.K. Vaccines For Children (VFC) Revenue (2017-2028) & (US$ Million)
    Figure 52. Italy Vaccines For Children (VFC) Revenue (2017-2028) & (US$ Million)
    Figure 53. Russia Vaccines For Children (VFC) Revenue (2017-2028) & (US$ Million)
    Figure 54. Asia Pacific Vaccines For Children (VFC) Sales Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Vaccines For Children (VFC) Revenue Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Vaccines For Children (VFC) Sales Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Vaccines For Children (VFC) Revenue Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Vaccines For Children (VFC) Sales Share by Region (2017-2028)
    Figure 59. Asia Pacific Vaccines For Children (VFC) Revenue Share by Region (2017-2028)
    Figure 60. China Vaccines For Children (VFC) Revenue (2017-2028) & (US$ Million)
    Figure 61. Japan Vaccines For Children (VFC) Revenue (2017-2028) & (US$ Million)
    Figure 62. South Korea Vaccines For Children (VFC) Revenue (2017-2028) & (US$ Million)
    Figure 63. India Vaccines For Children (VFC) Revenue (2017-2028) & (US$ Million)
    Figure 64. Australia Vaccines For Children (VFC) Revenue (2017-2028) & (US$ Million)
    Figure 65. Taiwan Vaccines For Children (VFC) Revenue (2017-2028) & (US$ Million)
    Figure 66. Indonesia Vaccines For Children (VFC) Revenue (2017-2028) & (US$ Million)
    Figure 67. Thailand Vaccines For Children (VFC) Revenue (2017-2028) & (US$ Million)
    Figure 68. Malaysia Vaccines For Children (VFC) Revenue (2017-2028) & (US$ Million)
    Figure 69. Philippines Vaccines For Children (VFC) Revenue (2017-2028) & (US$ Million)
    Figure 70. Latin America Vaccines For Children (VFC) Sales Market Share by Type (2017-2028)
    Figure 71. Latin America Vaccines For Children (VFC) Revenue Market Share by Type (2017-2028)
    Figure 72. Latin America Vaccines For Children (VFC) Sales Market Share by Application (2017-2028)
    Figure 73. Latin America Vaccines For Children (VFC) Revenue Market Share by Application (2017-2028)
    Figure 74. Latin America Vaccines For Children (VFC) Sales Share by Country (2017-2028)
    Figure 75. Latin America Vaccines For Children (VFC) Revenue Share by Country (2017-2028)
    Figure 76. Mexico Vaccines For Children (VFC) Revenue (2017-2028) & (US$ Million)
    Figure 77. Brazil Vaccines For Children (VFC) Revenue (2017-2028) & (US$ Million)
    Figure 78. Argentina Vaccines For Children (VFC) Revenue (2017-2028) & (US$ Million)
    Figure 79. Middle East and Africa Vaccines For Children (VFC) Sales Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Vaccines For Children (VFC) Revenue Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa Vaccines For Children (VFC) Sales Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Vaccines For Children (VFC) Revenue Market Share by Application (2017-2028)
    Figure 83. Middle East and Africa Vaccines For Children (VFC) Sales Share by Country (2017-2028)
    Figure 84. Middle East and Africa Vaccines For Children (VFC) Revenue Share by Country (2017-2028)
    Figure 85. Turkey Vaccines For Children (VFC) Revenue (2017-2028) & (US$ Million)
    Figure 86. Saudi Arabia Vaccines For Children (VFC) Revenue (2017-2028) & (US$ Million)
    Figure 87. UAE Vaccines For Children (VFC) Revenue (2017-2028) & (US$ Million)
    Figure 88. Vaccines For Children (VFC) Value Chain
    Figure 89. Vaccines For Children (VFC) Production Process
    Figure 90. Channels of Distribution
    Figure 91. Distributors Profiles
    Figure 92. Bottom-up and Top-down Approaches for This Report
    Figure 93. Data Triangulation
    Figure 94. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
GSK
Sanofi
Merck
Pfizer
Jintan
CSL
MedImmune LLC
J&J(Crucell)
China National Biotec
Tiantan
Hualan
Kangtai
Hissen
Frequently Asked Questions
Vaccines For Children (VFC) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Vaccines For Children (VFC) report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Vaccines For Children (VFC) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

DTaP Vaccine

DTaP Vaccine market is segmented by Type and by Application. Players, stakeholders, and other par ... Read More